387 related articles for article (PubMed ID: 8567354)
1. Pulsed dose rate and fractionated high dose rate brachytherapy: choice of brachytherapy schedules to replace low dose rate treatments.
Visser AG; van den Aardweg GJ; Levendag PC
Int J Radiat Oncol Biol Phys; 1996 Jan; 34(2):497-505. PubMed ID: 8567354
[TBL] [Abstract][Full Text] [Related]
2. Equivalence of hyperfractionated and continuous brachytherapy in a rat tumor model and remarkable effectiveness when preceded by external irradiation.
Veninga T; Visser AG; van den Berg AP; van Hooije CM; van Geel CA; Levendag PC
Int J Radiat Oncol Biol Phys; 2001 Apr; 49(5):1351-60. PubMed ID: 11286843
[TBL] [Abstract][Full Text] [Related]
3. Clinical implications of incomplete repair parameters for rat spinal cord: the feasibility of large doses per fraction in PDR and HDR brachytherapy.
Pop LA; Millar WT; Visser AG; van der Kogel AJ
Int J Radiat Oncol Biol Phys; 2001 Sep; 51(1):215-26. PubMed ID: 11516872
[TBL] [Abstract][Full Text] [Related]
4. Constraints in the use of repair half times and mathematical modelling for the clinical application of HDR and PDR treatment schedules as an alternative for LDR brachytherapy.
Pop LA; van den Broek JF; Visser AG; van der Kogel AJ
Radiother Oncol; 1996 Feb; 38(2):153-62. PubMed ID: 8966228
[TBL] [Abstract][Full Text] [Related]
5. Biological effect of pulsed dose rate brachytherapy with stepping sources if short half-times of repair are present in tissues.
Fowler JF; Van Limbergen EF
Int J Radiat Oncol Biol Phys; 1997 Mar; 37(4):877-83. PubMed ID: 9128965
[TBL] [Abstract][Full Text] [Related]
6. The optimal fraction size in high-dose-rate brachytherapy: dependency on tissue repair kinetics and low-dose rate.
Sminia P; Schneider CJ; Fowler JF
Int J Radiat Oncol Biol Phys; 2002 Mar; 52(3):844-9. PubMed ID: 11849810
[TBL] [Abstract][Full Text] [Related]
7. Fractionated high-dose-rate and pulsed-dose-rate brachytherapy: first clinical experience in squamous cell carcinoma of the tonsillar fossa and soft palate.
Levendag PC; Schmitz PI; Jansen PP; Senan S; Eijkenboom WM; Sipkema D; Meeuwis CA; Kolkman-Deurloo IK; Visser AG
Int J Radiat Oncol Biol Phys; 1997 Jun; 38(3):497-506. PubMed ID: 9231672
[TBL] [Abstract][Full Text] [Related]
8. Radiobiological equivalent of low/high dose rate brachytherapy and evaluation of tumor and normal responses to the dose.
Manimaran S
Radiat Med; 2007 Jun; 25(5):229-35. PubMed ID: 17581712
[TBL] [Abstract][Full Text] [Related]
9. The implementation of the Gynaecological Groupe Européen de Curiethérapie - European Society for Therapeutic Radiology and Oncology radiobiology considerations in the conversion of low dose rate to pulsed dose rate treatment schedules for gynaecological brachytherapy.
Baker S; Pooler A; Hendry J; Davidson S
Clin Oncol (R Coll Radiol); 2013 Apr; 25(4):265-71. PubMed ID: 23218875
[TBL] [Abstract][Full Text] [Related]
10. High-dose-rate and pulsed-dose-rate brachytherapy for oral cavity cancer and oropharynx cancer.
Polo A
J Contemp Brachytherapy; 2009 Dec; 1(4):216-223. PubMed ID: 28050175
[TBL] [Abstract][Full Text] [Related]
11. LDR vs. HDR brachytherapy for localized prostate cancer: the view from radiobiological models.
King CR
Brachytherapy; 2002; 1(4):219-26. PubMed ID: 15062170
[TBL] [Abstract][Full Text] [Related]
12. Low-dose-rate brachytherapy is superior to high-dose-rate brachytherapy for bladder cancer.
Pos FJ; Horenblas S; Lebesque J; Moonen L; Schneider C; Sminia P; Bartelink H
Int J Radiat Oncol Biol Phys; 2004 Jul; 59(3):696-705. PubMed ID: 15183473
[TBL] [Abstract][Full Text] [Related]
13. High-dose-rate brachytherapy may be radiobiologically superior to low-dose rate due to slow repair of late-responding normal tissue cells.
Orton CG
Int J Radiat Oncol Biol Phys; 2001 Jan; 49(1):183-9. PubMed ID: 11163513
[TBL] [Abstract][Full Text] [Related]
14. Biologically effective doses in medium dose rate brachytherapy of cancer of the cervix.
Leborgne F; Fowler JF; Leborgne JH; Zubizarreta E; Chappell R
Radiat Oncol Investig; 1997; 5(6):289-99. PubMed ID: 9436246
[TBL] [Abstract][Full Text] [Related]
15. High-dose-rate versus low-dose-rate brachytherapy in the treatment of cervical cancer: analysis of tumor recurrence--the University of Wisconsin experience.
Petereit DG; Sarkaria JN; Potter DM; Schink JC
Int J Radiat Oncol Biol Phys; 1999 Dec; 45(5):1267-74. PubMed ID: 10613322
[TBL] [Abstract][Full Text] [Related]
16. [In vitro studies of PDR brachytherapy].
Fritz P; Frank C; Weber KJ
Strahlenther Onkol; 1998 Jul; 174(7):365-74. PubMed ID: 9689958
[TBL] [Abstract][Full Text] [Related]
17. Determination of the appropriate fraction number and size of the HDR brachytherapy for cervical cancer.
Liu WS; Yen SH; Chang CH; Yang KM; Wu YP; Chen KY
Gynecol Oncol; 1996 Feb; 60(2):295-300. PubMed ID: 8631555
[TBL] [Abstract][Full Text] [Related]
18. Patterns of brachytherapy practice for patients with carcinoma of the cervix (1996-1999): a patterns of care study.
Erickson B; Eifel P; Moughan J; Rownd J; Iarocci T; Owen J
Int J Radiat Oncol Biol Phys; 2005 Nov; 63(4):1083-92. PubMed ID: 16099599
[TBL] [Abstract][Full Text] [Related]
19. Is pulsed dose rate more damaging to spinal cord of rats than continuous low dose rate?
Haustermans K; Fowler J; Landuyt W; Lambin P; van der Kogel A; van der Schueren E
Radiother Oncol; 1997 Oct; 45(1):39-47. PubMed ID: 9364630
[TBL] [Abstract][Full Text] [Related]
20. Pulsed-dose-rate brachytherapy: design of convenient (daytime-only) schedules.
Brenner DJ; Schiff PB; Huang Y; Hall EJ
Int J Radiat Oncol Biol Phys; 1997 Nov; 39(4):809-15. PubMed ID: 9369127
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
